| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Ms. Eva Anette EngelhardtExec. VP & President of the Clinical Diagnostics Group | -550.00 | 135.60k | 売り | 246.54 | 346.00 | -61.38% |
| 2026-04-24 | Mr. Roop K. LakkarajuExec. VP & CFO | -420.00 | 120.89k | Derivative Exercise and Sale | 287.84 | 2.56k | - |
| 2026-04-24 | Mr. Roop K. LakkarajuExec. VP & CFO | 658.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.56k | 34.52% |
| 2026-04-24 | Ms. Courtney C. EnloeExec. VP, General Counsel & Secretary | -77.00 | 22.16k | Derivative Exercise and Sale | 287.84 | 750.00 | - |
| 2026-04-24 | Ms. Courtney C. EnloeExec. VP, General Counsel & Secretary | 109.00 | 0.00 | Derivative Exercise and Retained Stock | - | 750.00 | 17.00% |
| 2026-04-21 | Mr. Gregory K. HinckleyLead Independent Director | 407.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.22k | 50.37% |
| 2026-04-21 | Ms. Melinda Litherland PeiIndependent Director | 407.00 | 0.00 | Derivative Exercise and Retained Stock | - | 715.00 | 132.14% |
| 2026-04-21 | Mr. Jeffrey L. EdwardsIndependent Director | 407.00 | 0.00 | Derivative Exercise and Retained Stock | - | 715.00 | 132.14% |
| 2026-04-21 | Mr. Arnold A. PinkstonIndependent Director | 407.00 | 0.00 | Derivative Exercise and Retained Stock | - | 715.00 | 132.14% |
| 2025-11-06 | Mr. James J. BarryExec. VP & President of Life Science Group | -699.87 | 214.29k | 売り | 306.18 | 510.00 | -57.85% |
| 2025-10-24 | Mr. Jonathan P. DiVincenzoPresident & COO | 919.00 | 0.00 | Derivative Exercise and Retained Stock | - | 919.00 | - |
| 2025-10-24 | Mr. Jonathan P. DiVincenzoPresident & COO | -950.00 | 322.76k | Derivative Exercise and Sale | 339.75 | 919.00 | - |
| 2025-10-20 | Mr. Sedat EvranExec. VP of Global Supply Chain | 709.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.23k | 46.52% |
| 2025-10-20 | Mr. Sedat EvranExec. VP of Global Supply Chain | -335.00 | 107.84k | Derivative Exercise and Sale | 321.90 | 2.23k | - |
| 2025-09-06 | Mr. Sedat EvranExec. VP of Global Supply Chain | 587.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.52k | 62.65% |
| 2025-09-06 | Mr. Sedat EvranExec. VP of Global Supply Chain | -277.00 | 81.83k | Derivative Exercise and Sale | 295.43 | 1.52k | - |
| 2025-09-06 | Mr. Roop K. LakkarajuExec. VP & CFO | 985.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.84k | 114.67% |
| 2025-09-06 | Mr. Roop K. LakkarajuExec. VP & CFO | -550.00 | 162.49k | Derivative Exercise and Sale | 295.43 | 1.84k | - |
| 2025-09-06 | Ms. Colleen Coreyインサイダー | 367.00 | 0.00 | Derivative Exercise and Retained Stock | - | 19.55k | 1.91% |
| 2025-09-06 | Ms. Colleen Coreyインサイダー | -209.00 | 61.74k | Derivative Exercise and Sale | 295.43 | 19.55k | - |
| 2025-09-06 | Mr. James J. BarryExec. VP & President of Life Science Group | 678.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.21k | 127.44% |
| 2025-09-06 | Mr. James J. BarryExec. VP & President of Life Science Group | -378.00 | 111.67k | Derivative Exercise and Sale | 295.43 | 1.21k | - |
| 2025-09-06 | Ms. Allison SchwartzDirector | 59.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.46k | 4.22% |
| 2025-09-06 | Ms. Allison SchwartzDirector | -33.00 | 9.75k | Derivative Exercise and Sale | 295.43 | 1.46k | - |
| 2025-09-06 | Ms. Eva Anette EngelhardtExec. VP & President of the Clinical Diagnostics Group | 739.00 | 0.00 | Derivative Exercise and Retained Stock | - | 896.00 | 470.70% |
| 2025-09-06 | Ms. Eva Anette EngelhardtExec. VP & President of the Clinical Diagnostics Group | -413.00 | 122.01k | Derivative Exercise and Sale | 295.43 | 896.00 | - |
| 2025-09-06 | Mr. Norman D. SchwartzChairman & CEO | 1.93k | 0.00 | Derivative Exercise and Retained Stock | - | 807.08k | 0.24% |
| 2025-09-06 | Mr. Norman D. SchwartzChairman & CEO | -1.53k | 451.42k | Derivative Exercise and Sale | 295.43 | 807.08k | - |
| 2025-09-06 | Ms. Courtney C. EnloeExec. VP, General Counsel & Secretary | 493.00 | 0.00 | Derivative Exercise and Retained Stock | - | - | - |
| 2025-09-06 | Ms. Courtney C. EnloeExec. VP, General Counsel & Secretary | -275.00 | 81.24k | Derivative Exercise and Sale | 295.43 | - | - |
| 2025-09-01 | Ms. Allison SchwartzDirector | 92.00 | 0.00 | Derivative Exercise and Retained Stock | - | 1.40k | 7.05% |
| 2025-09-01 | Ms. Allison SchwartzDirector | -55.00 | 16.38k | Derivative Exercise and Sale | 297.88 | 1.40k | - |
| 2025-09-01 | Mr. James J. BarryExec. VP & President of Life Science Group | 385.00 | 0.00 | Derivative Exercise and Retained Stock | - | 532.00 | 261.90% |
| 2025-09-01 | Mr. James J. BarryExec. VP & President of Life Science Group | -217.00 | 64.64k | Derivative Exercise and Sale | 297.88 | 532.00 | - |
| 2025-09-01 | Ms. Colleen Coreyインサイダー | 704.00 | 0.00 | Derivative Exercise and Retained Stock | - | 19.18k | 3.81% |
| 2025-09-01 | Ms. Colleen Coreyインサイダー | -398.00 | 118.56k | Derivative Exercise and Sale | 297.88 | 19.18k | - |
| 2025-09-01 | Mr. Norman D. SchwartzChairman & CEO | 3.27k | 0.00 | Derivative Exercise and Retained Stock | - | 805.15k | 0.41% |
| 2025-09-01 | Mr. Norman D. SchwartzChairman & CEO | -3.08k | 918.66k | Derivative Exercise and Sale | 297.88 | 805.15k | - |
| 2025-07-25 | Ms. Eva Anette EngelhardtExec. VP & President of the Clinical Diagnostics Group | 157.00 | 0.00 | Derivative Exercise and Retained Stock | - | 157.00 | - |
| 2025-07-25 | Ms. Eva Anette EngelhardtExec. VP & President of the Clinical Diagnostics Group | -88.00 | 23.25k | Derivative Exercise and Sale | 264.19 | 157.00 | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。